Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.
Mannan-binding lectin (MBL) is an acute phase protein which activates the classical complement pathway at the level of C4 and C2 via two novel serine proteases homologous to C1r and C1s. We recently reported that haemolysis via this lectin pathway requires alternative pathway amplification. The present experiments sought to establish the basis for this requirement, and hence focused on the activity and regulation of the C3 convertases. Complement activation was normalized between the lectin and classical pathways such that identical amounts of bound C4 and of haemolytically active C4,2 sites were present on the indicator cells. Under these conditions, there was markedly less haemolysis, associated with markedly less C3 and C5 deposited, via the lectin pathway than via the classical pathway, particularly when alternative pathway recruitment was blocked by depletion of factor D. Lectin pathway activation was associated with enhanced binding in the presence of MBL of complement control proteins C4bp and factor H to C4b and C3b, respectively, with decreased stability of the C3-converting enzyme C4b,2a attributable to C4bp. Immunodepletion of C4bp and/or factor H increased lectin pathway haemolysis and allowed lysis to occur in absence of the alternative pathway. Thus, the lectin pathway of humans is particularly susceptible to the regulatory effects of C4bp and factor H, due at least in part to MBL enhancement of C4bp binding to C4b and factor H binding to C3b.
Suankratay
C
C
Department of Immunology/Microbiology, Rush Medical College, Chicago, IL 60612, USA.
Mold
C
C
Zhang
Y
Y
Lint
T F
TF
Gewurz
H
H
D000818:Animals; D002352:Carrier Proteins / Q000276:immunology*; D037222:Collectins; D050577:Complement C3-C5 Convertases / Q000096:biosynthesis; D003179:Complement C3b / Q000276:immunology; D003181:Complement C4 / Q000276:immunology; D050716:Complement C4b-Binding Protein; D003182:Complement C5 / Q000276:immunology; D050776:Complement C5b; D017242:Complement Factor H / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology*; D004790:Enzyme Induction; D004912:Erythrocytes / Q000276:immunology; D006461:Hemolysis; D006649:Histocompatibility Antigens / Q000276:immunology*; D006801:Humans; D037102:Lectins / Q000276:immunology*; D008351:Mannans / Q000276:immunology*; D011414:Properdin / Q000276:immunology; D012756:Sheep
C055609:C4BPA protein, human; C489165:C4BPB protein, human; C493495:CFH protein, human; D002352:Carrier Proteins; D037222:Collectins; D003181:Complement C4; D050716:Complement C4b-Binding Protein; D003182:Complement C5; D006649:Histocompatibility Antigens; D037102:Lectins; D008351:Mannans; D011414:Properdin; D003179:Complement C3b; D050776:Complement C5b; D017242:Complement Factor H; D003165:Complement System Proteins; D050577:Complement C3-C5 Convertases